A case report of isolated arrhythmogenic left ventricular cardiomyopathy: phenotypes, diagnosis, and treatment

Yang Lan1, Lai Wei2, Cuizhen Pan3

  • 1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai 200032, China.

PubMed

Insights

Isolated arrhythmogenic left ventricular cardiomyopathy (IALVC) is a rare genetic heart condition. Early diagnosis via multimodal imaging and genetic analysis, alongside treatments like ICD implantation, improves patient outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Isolated arrhythmogenic left ventricular cardiomyopathy (IALVC) is a hereditary condition where heart muscle is replaced by fibrous and adipose tissue.
  • This condition primarily affects the left ventricle, distinguishing it from other forms of arrhythmogenic cardiomyopathy.

Observation:

  • A 55-year-old male presented with chest pain and palpitations, experiencing ventricular tachycardia and T-wave inversion.
  • Diagnostic workup included coronary angiography, echocardiography revealing ventricular aneurysm, and cardiac MRI confirming IALVC.
  • Whole exome sequencing identified a TTN1 c.17617 C>A mutation, confirming the genetic basis of the disease.

Findings:

  • Multimodal imaging and histopathology confirmed IALVC with apical fibrofatty displacement.
  • The TTN1 gene mutation was identified as the likely cause of the patient's condition.
  • The patient's symptoms significantly improved following treatment.

Implications:

  • This case underscores the importance of integrating imaging, genetic, and pathological data for accurate IALVC diagnosis.
  • Effective management strategies include implantable cardioverter defibrillator (ICD) implantation, radiofrequency ablation, and surgical resection of ventricular aneurysms.
  • Understanding the clinical presentation and treatment outcomes of IALVC contributes to improved patient care and disease management.
Abstract